TICKERNERD
Menu
HYFTHYFTHealthcare · Biotechnology

HYFT Stock Forecast: MindWalk Holdings Corp. Price Predictions for 2026-2027

Last close, 5 Oct 2026
$1.49
+11.19% on the day

The 3 Wall Street analysts covering MindWalk Holdings Corp. hold a median 12-month price target of $5 — +235.6% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 51 of 100 as at 3 Oct 2026 — in the upper half.

Market cap
$70.2M
Ticker Nerd rank
51 / 100
Median analyst target
$5.00
Analysts covering
3
Revenue$4.1M−41.1% y/y
Operating income−$4.3M
Net income−$3.9M
Free cash flow−$2.4M
Quarterly, 8 quarters to 30 Apr 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+11.2%
1M
+12.9%
YTD
−18.1%
1Y
−11.8%
From 52W high
−46.4%
From 52W low
+46.1%
$1.02
$2.78
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

HYFT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores MindWalk Holdings Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Oct 2026
51 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
90
Size
80
Issuance
62
Growth
49
Quality
47
Value
44
Momentum
43
Volatility
32
Revisions
26

Accruals (90): Reported profit is backed by cash, and the company is not expanding recklessly.

Revisions (26): Analysts have, on balance, been cutting their forecasts.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

HYFT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on HYFT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$2.00$3.00$4.00$5.00Jan 26Apr 26Jul 26Oct 26HYFTHigh $5.00Median $5.00Low $3.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $3.00Median $5.00High $5.00

The green dot is the last close — the median target sits +235.6% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
19 May 2026HC Wainwright & Co.ReiteratesBuy$5.00
16 Apr 2026Jones TradingInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. HYFT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

HYFT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 5 Oct 2026, MindWalk Holdings Corp. returned −11.8% against +17.0% for the S&P 500, dividends included.

HYFT vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120140160Jan 26Apr 26Jul 26Oct 26HYFTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

HYFT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
3
Fundamentals

MindWalk Holdings Corp. (HYFT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−4.7×

Cheaper than 89% of US stocks

Price / sales
4.3×

Cheaper than 31% of US stocks

Price / book
14.4×

Cheaper than 7% of US stocks

EV / EBITDA
−4.1×

Cheaper than 77% of US stocks

Growth & margins
Revenue growth (YoY)
21.3%

Higher than 70% of US stocks

Earnings growth (YoY)
−41.1%

Higher than 13% of US stocks

Gross margin
60.6%

Higher than 74% of US stocks

Operating margin
−159.9%

Higher than 12% of US stocks

Net margin
−105.2%

Higher than 6% of US stocks

Returns & dividend
Return on equity
−123.7%

Higher than 11% of US stocks

Return on assets
−36.4%

Higher than 12% of US stocks

Dividend yield
0.0%

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

MindWalk Holdings Corp. (HYFT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • MindWalk Holdings Corp. has a market value of $70.2M and an enterprise value of $46.4M.

  • Revenue in the twelve months to 30 Apr 2026: $15.6M. The latest quarter grew 21.3% year on year.

  • Net income over the same four quarters: −$13.9M, a −89.7% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.30.

  • Free cash flow in the twelve months to 30 Apr 2026: −$12.9M, after $398K of capital spending.

  • Shares outstanding: 46.7M.

  • Trailing P/E: −4.7×; forward P/E: −5.8× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • MindWalk Holdings Corp. employs 74 people — $210K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 Apr 2026 · market figures as at 6 Oct 2026

Data provided by Twelve Data

Peers

HYFT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
HYFTMindWalk Holdings Corp.$70.2M
51
ELOXEloxx Pharmaceuticals, Inc.$62.6M
12
ACETAdicet Bio, Inc.$62.3M
40
INKTMiNK Therapeutics, Inc.$61.8M
61
PLRXPliant Therapeutics, Inc.$64.1M
67
GUTSFractyl Health, Inc.$64.5M
30
GOSSGossamer Bio, Inc.$65.4M
50

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own MindWalk Holdings Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest HYFT news & analysis

MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director

Business Wire · 1 Oct 2026neutral

MindWalk Holdings Corp. announced the appointment of Kim Remizowski as an independent director to its Board of Directors, effective September 29, 2026. He will serve on the Audit Committee and the Compensation, Nomination and Governance Committee, and has been determined to qualify as an audit committee financial expert under Nasdaq rules.

Why it matters — The addition of a qualified independent director strengthens the company's board governance and audit oversight.

MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine

Business Wire · 21 Sept 2026positive

MindWalk announced results from a production deployment of the open-source OpenFold3 structure prediction model, run with partners AMD and Vultr on Vultr Kubernetes Engine and AMD Instinct MI325X GPUs via AMD Inference Microservices. The deployment also served as an independent validation of AMD's AIM platform for OpenFold3 in a production life-sciences setting.

Why it matters — For HYFT watchers, this demonstrates MindWalk's ability to bring its Bio-Native AI models into production with major technology partners, signaling real-world deployment capability in life sciences.

MindWalk Holdings Corp. (HYFT) Q1 2027 Earnings Call Transcript

Seeking Alpha · 14 Sept 2026neutral

MindWalk Holdings Corp. (HYFT) held its Q1 2027 earnings call, and Seeking Alpha published a transcript of the event. The item identifies the company's first-quarter 2027 earnings call as the subject, with the full transcript made available.

Why it matters — A HYFT watcher would care because the Q1 2027 earnings call transcript provides direct insight into management's comments during the company's quarterly results discussion.

MindWalk Holdings Corp. (HYFT) Reports Q1 Loss, Misses Revenue Estimates

Zacks Investment Research · 14 Sept 2026negative

MindWalk Holdings Corp. (HYFT) reported a Q1 loss of $0.09 per share, wider than the Zacks Consensus Estimate of a $0.05 loss and larger than the $0.07 per share loss posted a year ago. The company also missed revenue estimates for the quarter.

Why it matters — A HYFT watcher would care because the company's quarterly loss came in wider than both analyst expectations and its year-ago result.

MindWalk Q1 Earnings Call Highlights

MarketBeat · 14 Sept 2026positive

MindWalk (NASDAQ: HYFT) reported first-quarter fiscal 2027 revenue of CAD 3.8 million, up 21% from CAD 3.2 million a year earlier, while continuing to invest in commercializing its ReefIQ biological-data platform and expanding its drug discovery partnership model.

Why it matters — The 21% revenue increase and continued investment in ReefIQ commercialization signal progress that HYFT watchers would track as the company develops its data platform and partnership model.

FAQ

Frequently asked questions about HYFT stock

What is the HYFT stock price forecast for 2026-2027?

The 3 Wall Street analysts covering MindWalk Holdings Corp. have a median 12-month price target of $5, with estimates ranging from $3 to $5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is HYFT stock a buy right now?

Of the 3 analysts covering MindWalk Holdings Corp., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks MindWalk Holdings Corp. 51 out of 100 across roughly 4,600 US stocks as at 3 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank HYFT?

As at 3 Oct 2026, MindWalk Holdings Corp. ranks 51 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (90 of 100).

Will HYFT stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +235.6% from the last close, and Ticker Nerd's factor model ranks MindWalk Holdings Corp. 51 out of 100 as at 3 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the HYFT stock forecast for 2030?

No analyst covering MindWalk Holdings Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for HYFT are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $3 to $5 over the next 12 months.

How has HYFT stock performed over the past year?

MindWalk Holdings Corp. returned -11.8% over the 12 months to 5 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does MindWalk Holdings Corp. do?

MindWalk Holdings Corp. operates as a bio-native AI company.

What is the latest news on HYFT?

The most recent item we track (Business Wire, 1 Oct 2026): "MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director". MindWalk Holdings Corp. announced the appointment of Kim Remizowski as an independent director to its Board of Directors, effective September 29, 2026. He will serve on the Audit Committee and the Compensation, Nomination and Governance Committee, and has been determined to qualify as an audit committee financial expert under Nasdaq rules.

Company

About MindWalk Holdings Corp.

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

CEO Dr. Jennifer Lynne Bath Ph.D. · 74 employees · United States · https://www.mindwalkai.com